Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Chemi Enoxaparin vs Clexane in Healthy Volunteers
NCT02232802Phase 1Completed
- Sponsor
- Chemi S.p.A.
- Start
- Aug 2014
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of enoxaparin in venous thromboembolism (VTE) (2 arms), sponsored by Chemi S.p.A. Primary endpoints: Maximum Observed Plasma Anti-FXa Activity, Maximum Observed Plasma Anti-FIIa Activity and 2 more. Started Aug 2014; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02232802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02232802.